ProMIS Neurosciences Inc. SEC filings PMN

ProMIS Neurosciences Inc. has 373 filings in SEC EDGAR's recent list, going back to Aug 29, 2006. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 9, 2026 Dec 31, 2025
10-K Annual report Mar 25, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
10-K Annual report Mar 31, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
10-K Annual report Apr 1, 2024 Dec 31, 2023
ARS Annual report to shareholders Jun 1, 2023 Dec 31, 2022
10-K/A Amended annual report Apr 27, 2023 Dec 31, 2022
10-K Annual report Mar 8, 2023 Dec 31, 2022
ARS Annual report to shareholders Jul 19, 2010 Mar 31, 2010
ARS Annual report to shareholders Jun 16, 2009 Mar 31, 2009
ARS Annual report to shareholders Feb 6, 2007 Mar 31, 2006

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PMN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Canada (Federal Level)
Headquarters
Toronto, Ontario, Canada
SEC filer status
, Emerging growth company
SEC CIK
1374339
Former names
AMORFIX LIFE SCIENCES LTD (until Nov 3, 2014)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.